Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shi, Lanbo ^a   Salamon, Hugh ^b   Eugenin, Eliseo A ^a   Pine, Richard ^a   Cooper, Andrea ^c   Gennaro, Maria L ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b Knowledge Synthesis Inc   (United States)

^c TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PYRUVATE DEHYDROGENASE COMPLEX; TRANSCRIPTOME;

ANIMAL; CITRIC ACID CYCLE; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLYCOLYSIS; HOMEOSTASIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG; LUNG TUBERCULOSIS; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; PH; PHYSIOLOGY;

ANIMALS; BIOMARKERS; CITRIC ACID CYCLE; ENERGY METABOLISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOLYSIS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG; MACROPHAGES; METABOLIC NETWORKS AND PATHWAYS; MICE; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE PHOSPHORYLATION; PYRUVATE DEHYDROGENASE COMPLEX; TRANSCRIPTOME; TUBERCULOSIS, PULMONARY;

EID: 84949575420     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18176     Document Type: Article

References (84)

1. Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633-643 (2013).
2. Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annu Rev Immunol 32, 609-634 (2014).
3. Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742-4749 (2010).
4. O'Neill, L. A. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346-355 (2013).
5. Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208, 1367-1376 (2011).
6. Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4 + T cell subsets. J Immunol 186, 3299-3303 (2011).
7. Macintyre, A. N. & Rathmell, J. C. Activated lymphocytes as a metabolic model for carcinogenesis. Cancer Metab 1, 5 (2013).
8. Warburg, O. On the origin of cancer cells. Science 123, 309-314 (1956).
9. Semenza, G. L. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20, 51-56 (2010).
10. Imtiyaz, H. Z. & Simon, M. C. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345, 105-120 (2011).
11. Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9, 609-617 (2009).
12. Peyssonnaux, C. et al. Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J Immunol 178, 7516-7519 (2007).
13. Molloy, S. Viral infection: KSHV flicks the metabolic switch. Nat Rev Microbiol 12, 723-723 (2014).
14. Russell, D. G. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5, 39-47 (2007).
15. Ehlers, S. & Schaible, U. E. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol 3, 411 (2013).
16. Prezzemolo, T. et al. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Front Immunol 5, 180 (2014).
17. Zuniga, J. et al. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol 2012, 193923 (2012).
18. Cooper, A. M. & Khader, S. A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226, 191-204 (2008).
19. Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R. & North, R. J. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193, 271-280 (2001).
20. Shi, L., Jung, Y. J., Tyagi, S., Gennaro, M. L. & North, R. J. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci USA 100, 241-246 (2003).
21. Khader, S. A. et al. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol 183, 8004-8014 (2009).
22. Mueckler, M. & Thorens, B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 34, 121-138 (2013).
23. Thorens, B. & Mueckler, M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298, E141-145 (2010).
24. Augustin, R. The protein family of glucose transport facilitators: It's not only about glucose after all. IUBMB Life 62, 315-333 (2010).
25. Doege, H., Bocianski, A., Joost, H. G. & Schurmann, A. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 350, 771-776 (2000).
26. Wilson, J. E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206, 2049-2057 (2003).
27. Ronimus, R. S. & Morgan, H. W. Cloning and biochemical characterization of a novel mouse ADP-dependent glucokinase. Biochem Biophys Res Commun 315, 652-658 (2004).
28. Mehrotra, P. et al. Pathogenicity of Mycobacterium tuberculosis is expressed by regulating metabolic thresholds of the host macrophage. PLoS Pathog 10, e1004265 (2014).
29. Mor, I., Cheung, E. C. & Vousden, K. H. Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb Symp Quant Biol 76, 211-216 (2011).
30. Dunaway, G. A. & Kasten, T. P. Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues. Biochem J 242, 667-671 (1987).
31. Okar, D. A. et al. PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26, 30-35 (2001).
32. Pilkis, S. J., Claus, T. H., Kurland, I. J. & Lange, A. J. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Annu Rev Biochem 64, 799-835 (1995).
33. Rodriguez-Prados, J. C. et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 185, 605-614 (2010).
34. Hirata, T., Kato, M., Okamura, N., Fukasawa, M. & Sakakibara, R. Expression of human placental-type 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in various cells and cell lines. Biochem Biophys Res Commun 242, 680-684 (1998).
35. Hwang, T. L., Liang, Y., Chien, K. Y. & Yu, J. S. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics 6, 2259-2272 (2006).
36. Krasnov, G. S., Dmitriev, A. A., Snezhkina, A. V. & Kudryavtseva, A. V. Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target. Expert Opin Ther Targets 17, 681-693 (2013).
37. Ralser, M. et al. Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 6, 10 (2007).
38. Pancholi, V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58, 902-920 (2001).
39. Nakamura, N. et al. Disruption of a Spermatogenic Cell-Specific Mouse Enolase 4 (Eno4) Gene Causes Sperm Structural Defects and Male Infertility. Biol Reprod 88, 1-12 (2013).
40. Diaz-Ramos, A., Roig-Borrellas, A., Garcia-Melero, A. & Lopez-Alemany, R. alpha-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations. J Biomed Biotechnol 2012, 156795 (2012).
41. Hiraoka, B. Y., Sharief, F. S., Yang, Y. W., Li, W. H. & Li, S. S. L. The Cdna and Protein Sequences of Mouse Lactate Dehydrogenase-B-Molecular Evolution of Vertebrate Lactate-Dehydrogenase Gene-a (Muscle), Gene-B (Heart) and Gene-C (Testis). Eur J Biochem 189, 215-220 (1990).
42. Herling, A., Konig, M., Bulik, S. & Holzhutter, H. G. Enzymatic features of the glucose metabolism in tumor cells. FEBS J 278, 2436-2459 (2011).
43. Pan, L., Beverley, P. C. L. & Isaacson, P. G. Lactate-Dehydrogenase (Ldh) Isoenzymes and Proliferative Activity of Lymphoid-Cells-an Immunocytochemical Study. Clin Exp Immunol 86, 240-245 (1991).
44. Haschemi, A. et al. The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism. Cell Metab 15, 813-826 (2012).
45. Halestrap, A. P. The SLC16 gene family-Structure, role and regulation in health and disease. Mol Aspects Med 34, 337-349 (2013).
46. Halestrap, A. P. & Meredith, D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447, 619-628 (2004).
47. Tan, Z. et al. The Monocarboxylate Transporter 4 Is Required for Glycolytic Reprogramming and Inflammatory Response in Macrophages. J Biol Chem 290, 46-55 (2015).
48. Toei, M., Saum, R. & Forgac, M. Regulation and Isoform Function of the V-ATPases. Biochemistry 49, 4715-4723 (2010).
49. Heinemann, T. et al. Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics 57, 398-406 (1999).
50. Kim, J. W. & Dang, C. V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30, 142-150 (2005).
51. Bando, H. et al. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin Cancer Res 11, 5784-5792 (2005).
52. Shin, J. H. et al. (1)H NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res 10, 2238-2247 (2011).
53. Somashekar, B. S. et al. Metabolic Profiling of Lung Granuloma in Mycobacterium tuberculosis Infected Guinea Pigs: Ex vivo H-1 Magic Angle Spinning NMR Studies. J Proteome Res 10, 4186-4195 (2011).
54. Somashekar, B. S. et al. Metabolomic Signatures in Guinea Pigs Infected with Epidemic-Associated W-Beijing Strains of Mycobacterium tuberculosis. J Proteome Res 11, 4873-4884 (2012).
55. Patra, K. C. & Hay, N. The pentose phosphate pathway and cancer. Trends Biochem Sci 39, 347-354 (2014).
56. Subbian, S., Eugenin, E. & Kaplan, G. Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy. J Med Microbiol 63, 1432-1435 (2014).
57. Harjes, U., Bensaad, K. & Harris, A. L. Endothelial cell metabolism and implications for cancer therapy. Br J Cancer 107, 1207-1212 (2012).
58. Palsson-McDermott, E. M. & O'Neill, L. A. J. The Warburg effect then and now: From cancer to inflammatory diseases. Bioessays 35, 965-973 (2013).
59. Wang, G. L. & Semenza, G. L. Purification and Characterization of Hypoxia-Inducible Factor-1. J Biol Chem 270, 1230-1237 (1995).
60. Werth, N. et al. Activation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens. PLoS One 5, e11567 (2010).
61. Cramer, T. et al. HIF-1 alpha is essential for myeloid cell-mediated inflammation. Cell 112, 5 645-657 (2003).
62. Kojima, H. et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1 alpha-deficient chimeric mice. Proc Natl Acad Sci USA 99, 2170-2174 (2002).
63. Zinkernagel, A. S., Johnson, R. S. & Nizet, V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) 85, 1339-1346 (2007).
64. Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9, 609-617 (2009).
65. Bruick, R. K. & McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340 (2001).
66. Epstein, A. C. R. et al. C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54 (2001).
67. Mahon, P. C., Hirota, K. & Semenza, G. L. FIH-1: a novel protein that interacts with HIF-1 alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15, 2675-2686 (2001).
68. Courtnay, R. et al. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 42, 841-851 (2015).
69. Gombart, A. F. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 4, 1151-1165 (2009).
70. Salamon, H. et al. Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J Immunol 193, 30-34 (2014).
71. Guirado, E. & Schlesinger, L. S. Modeling the Mycobacterium tuberculosis Granuloma-the Critical Battlefield in Host Immunity and Disease. Front Immunol 4, 98 (2013).
72. Coleman, M. T. et al. PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis. Sci Transl Med 6, 265ra167 (2014).
73. Wyatt, E. et al. Regulation and Cytoprotective Role of Hexokinase III. PLoS One 5, e13823 (2010).
74. Sebastian, S., Edassery, S. & Wilson, J. E. The human gene for the type III isozyme of hexokinase: Structure, basal promoter, and evolution. Arch Biochem Biophys 395, 113-120 (2001).
75. Halestrap, A. P. & Wilson, M. C. The monocarboxylate transporter family-role and regulation. IUBMB Life 64, 109-119 (2012).
76. Imtiyaz, H. Z. & Simon, M. C. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345, 105-120 (2010).
77. Tormos, K. V. & Chandel, N. S. Inter-connection between mitochondria and HIFs. J Cell Mol Med 14, 795-804 (2010).
78. Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha. Nature 496, 238-242 (2013).
79. Jones, C. M. et al. Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling. Proc Natl Acad Sci USA 111, 1945-1950 (2014).
80. Takeda, N. et al. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev 24, 491-501 (2010).
81. Kellum, J. A., Song, M. & Li, J. Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 8, 331-336 (2004).
82. Lu, M., Kho, T. & Munford, R. S. Prolonged triglyceride storage in macrophages: pHo trumps pO2 and TLR4. J Immunol 193, 1392-1397 (2014).
83. Dhup, S., Dadhich, R. K., Porporato, P. E. & Sonveaux, P. Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis. Curr Pharm Des 18, 1319-1330 (2012).
84. Rella, C. E., Ruel, N. & Eugenin, E. A. Development of imaging techniques to study the pathogenesis of biosafety level 2/3 infectious agents. Pathog Dis 72, 167-173 (2014).